Clinical trial
A Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity
NCT03233867 is registered in ClinicalTrials.gov with Aevi Genomic Medicine, LLC, a Cerecor company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity
- Lead sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 14, 2017
- Completion date
- August 3, 2018
- Enrollment
- 2,503 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder